Can Delta Variant Effectiveness Fill Brazil-Sized Hole In Bharat Biotech’s Prospects?
Ocugen Class Action Suit Could Get Tricky
A study indicates that the Delta variant of SARS-CoV-2 and its sub-lineage Delta Plus can be neutralized by Bharat Biotech’s COVID-19 vaccine, but a federal investigation in Brazil and a class action suit against its US partner have hurt the firm’s global ambitions. Experts weigh in on what the future could possibly hold.
